Karlsruhe Institute of Technology
Kaiserstraße 12, Karlsruhe, Baden-Württemberg, 76131, Germany
Overview
The Karlsruhe Institute of Technology (KIT) is a German educational institution focused on research, teaching, and innovation. Thematic priorities of its research activities include energy, natural and built environment, and society and technology. The institute has over 9400 employees, including more than 6,000 in research and teaching, as well as 24,500 students. The Karlsruhe Institute of Technology was founded with the merger of Forschungszentrum Karlsruhe and the University of Karlsruhe. The university is based in Karlsruhe, Germany.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- EdTech
- Higher Education
- Universities
Investment portfolio
- amcure
Participated · Series B · Dec 2016
amcure GmbH is a biopharmaceutical company and 2012 spin-off from the Karlsruhe Institute of Technology developing peptide-based compounds for highly metastatic epithelial cancers. Its lead product, AMC303, is a CD44v6-targeting therapeutic designed to block signaling through VEGF/VEGFR-2, HGF/c-Met and MSP/RON pathways. AMC303 has shown strong effects in in vitro and in vivo assays and has entered a Phase I/Ib clinical trial, with the first patient treated at the end of October. The company plans to use new funding to continue and accelerate clinical development of AMC303. amcure is sponsored by a grant from the German Federal Ministry of Education and Research and aims to provide a novel mechanism for treating advanced, metastatic solid tumors. The company is based in Eggenstein-Leopoldshafen, Germany.